Longevity Health Holdings, Inc. (XAGE)
NASDAQ: XAGE · Real-Time Price · USD
0.1642
+0.0042 (2.63%)
At close: Apr 25, 2025, 4:00 PM
0.1562
-0.0080 (-4.87%)
Pre-market: Apr 28, 2025, 4:25 AM EDT

Longevity Health Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.05---
Cost of Revenue
0.01---
Gross Profit
0.04---
Selling, General & Admin
3.92.623.220.86
Research & Development
1.052.52.20.98
Operating Expenses
5.045.225.511.94
Operating Income
-5-5.22-5.51-1.94
Interest Expense
-0.05-0.89-3.75-2.5
Other Non Operating Income (Expenses)
-5.66-9.371.27-2.48
EBT Excluding Unusual Items
-10.7-15.48-7.99-6.92
Merger & Restructuring Charges
--0.73--
Other Unusual Items
-0.04--1.060.44
Pretax Income
-10.75-16.21-9.05-6.48
Income Tax Expense
-0.1---
Earnings From Continuing Operations
-10.65-16.21-9.05-6.48
Earnings From Discontinued Operations
0.280.76--
Net Income
-10.37-15.45-9.05-6.48
Preferred Dividends & Other Adjustments
-0.680.560.31
Net Income to Common
-10.37-16.12-9.61-6.79
Shares Outstanding (Basic)
2111223
Shares Outstanding (Diluted)
2111223
Shares Change (YoY)
93.83%527.34%-92.41%-
EPS (Basic)
-0.49-1.46-5.47-0.29
EPS (Diluted)
-0.49-1.46-5.47-0.29
Free Cash Flow
-4.39-8.38-3.44-1.18
Free Cash Flow Per Share
-0.20-0.76-1.96-0.05
Gross Margin
87.37%---
Operating Margin
-9933.82%---
Profit Margin
-20605.47%---
Free Cash Flow Margin
-8722.42%---
EBITDA
-4.92-5.12-5.41-1.85
D&A For EBITDA
0.080.10.090.09
EBIT
-5-5.22-5.51-1.94
Revenue as Reported
0.05---
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.